---
run_id: halo-evidence-vs-diagnosis-validation-v10-criteria-prompted-no-sources-06
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v10
benchmark_version: halo-evidence-vs-diagnosis-validation-v10-v1
model_condition: criteria_prompted_no_sources
run_number: 6
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 1024
seed: 606
prompt_source: condition packet (criteria_prompted_no_sources) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 61d771e2bff7fd2e18be1d2999d0f601760656e3e69b4622989ca7bffd3aff8e
source_packet: an abstract evidence-quality criteria reminder, then the frozen Advisor prompt; no source names, source cards, or case-specific answer hint - see run-packet.md
source_packet_sha256: 99e91b34c6105209d4266fed0bcb0ab798bcedfae3a4ab5516c3c91fc972adaa
condition_packet_sha256: 99e91b34c6105209d4266fed0bcb0ab798bcedfae3a4ab5516c3c91fc972adaa
output_file: model-outputs/criteria_prompted_no_sources-06.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - criteria_prompted_no_sources (run 06)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v10-v1`, condition `criteria_prompted_no_sources`, run 6 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 606, on the frozen condition packet.

## Output

**Recommendation: Run the Claim File Review.**

This is the only intervention that isolates whether the product provides actual utility or if current success is a byproduct of financial incentives and social pressure. The expansion bookings are contaminated by bundle pricing, and the positive customer comments are biased by a roadmap pitch that promises future value rather than confirming current value. Furthermore, usage data is misleading; high activity from managers rerunning samples does not equal adjuster adoption, and the drop-off in front-line use suggests a lack of trust or utility. By inspecting actual claim files, you bypass the "enablement" noise and reveal whether the software's output is actually being used to resolve claims or if it is being overridden and ignored.

**The strongest reason against this:**
It is a slow, manual process that provides a small sample size compared to the broad, quantitative data of a usage sprint. It will not provide an immediate "green light" for the board in twelve days and may reveal a failure that contradicts the current optimistic narrative of the executive team, potentially creating internal friction.

**Observable evidence that would change my mind:**
If you discover that the "impossible to explain" issue in health-liability is a simple UI/documentation gap rather than a fundamental failure of the logic, I would shift to narrowing the plan around regulated health-liability workflows. If that specific segment is the only place where the product's failure is visible, solving for the most constrained environment would likely unlock the rest of the market.
